Our solutions can be applied to multiple disease areas. We currently focus on oncology, infection disease and neurology, but we are continuously expanding our portfolio.
Our applications for prostate, bladder, and melanoma cancer are now live and actively deployed, and we are currently developing applications for melanoma and lung cancer. Additionally, breast cancer is on our development roadmap of 2024. If you would like to learn more about our developments or have inquiries about a specific disease area not included on the roadmap, please feel free to contact us or directly schedule a meeting us.
Schedule a demo to see how Health Economic Software can improve the market uptake of your products.